Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-2023 | 02-2023 | 11-2022 | 08-2022 | 05-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,067 | -8,582 | -3,937 | -33,045 | -10,429 |
| Depreciation Amortization | 6,105 | 5,370 | 2,077 | 8,993 | 6,004 |
| Accounts receivable | -309 | 58 | 28 | 457 | -3,650 |
| Accounts payable and accrued liabilities | 155 | 300 | 322 | 283 | 117 |
| Other Working Capital | -471 | 57 | 133 | -823 | -3,824 |
| Other Operating Activity | 2,573 | 1,641 | 1,099 | 18,251 | 5,222 |
| Operating Cash Flow | $-2,015 | $-1,157 | $-278 | $-5,884 | $-6,560 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | N/A | N/A | -190 | -191 |
| Net Acquisitions | N/A | N/A | N/A | 58 | 58 |
| Other Investing Activity | 0 | 0 | 0 | 296 | 296 |
| Investing Cash Flow | $-19 | $N/A | $0 | $164 | $163 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,147 | 445 | N/A | 15,270 | 15,270 |
| Debt Repayment | -6 | -4 | -3 | -18 | -15 |
| Common Stock Issued | 2,246 | 1,926 | 1,795 | N/A | 0 |
| Other Financing Activity | -3,091 | -2,972 | -2,826 | -15,679 | -4,453 |
| Financing Cash Flow | $296 | $-605 | $-1,034 | $-427 | $10,803 |
| Exchange Rate Effect | 22 | 193 | 12 | 33 | -21 |
| Beginning Cash Position | 2,179 | 2,179 | 2,179 | 8,293 | 8,293 |
| End Cash Position | 464 | 610 | 879 | 2,179 | 12,678 |
| Net Cash Flow | $-1,715 | $-1,569 | $-1,300 | $-6,115 | $4,384 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,015 | -1,157 | -278 | -5,884 | -6,560 |
| Capital Expenditure | -19 | N/A | N/A | -190 | -191 |
| Free Cash Flow | -2,033 | -1,157 | -278 | -6,074 | -6,751 |